More on the 23andMe Deal—Selling Consumers’ Data to Drug Companies

Aug 4, 2018 | DNA, DNA Testing and Drug Companies, Privacy and Data Protection

Perhaps you didn’t intend for that spit sample you shipped off to be used for research on antacids. But that could be what happens with some of the data that genetics-testing companies like Ancestry, 23andMe, and Helix have collected from billions of customers and stored in their databases.

Both Ancestry and 23andMe have a history of sharing anonymized consumer data with private companies, also known as “third parties.” Last week, 23andMe took that policy to a new level when it announced a plan to share the genetic data of millions of consumers with pharmaceutical giant GlaxoSmithKline to help the company develop new drugs.

Read the Business Insider article for more


Pin It on Pinterest